A Fatal Breakthrough COVID-19 Case Following Bendamustine-Rituximab Therapy

Kohei Kamegai,Noriko Iwamoto,Tomiteru Togano,Kenji Maeda,Yuki Takamatsu,Yusuke Miyazato,Masahiro Ishikane,Masashi Mizokami,Masaya Sugiyama,Shun Iida,Sho Miyamoto,Tadaki Suzuki,Norio Ohmagari

International Journal of Infectious Diseases（2022）

引用 1|浏览9

暂无评分

摘要

•We report a fatal case of breakthrough infection with the SARS-CoV-2 Delta variant after the first vaccination course.•Patients with hematologic malignancies are vulnerable to COVID-19 viral infection.•Surveillance of mixed alleles could help detect unknown aggravating factors.

查看译文

关键词

COVID-19,Breakthrough,Fatal,Bendamustine-rituximab therapy,Immune escape

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要